ClinicalTrialsFinder

Non-small Cell Lung Cancer Clinical Trials in Cheongju-si, North Chungcheong

1 recruitingCheongju-si, North Chungcheong, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC868 enrolled226 locationsNCT06077760